Quick Answer
Elanco Animal Health Inc reported Long Term Debt of $4.28 billion for the year ending 2024.
- Elanco Animal Health Inc showed a decrease of -25.4% in Long Term Debt from 2023 to 2024.
- This data is from Elanco Animal Health Inc's annual report (Form 10-K), filed with the SEC on February 25, 2025.
- XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $2.48 billion | Q1 2019: $2.44 billion | Q2 2019: $2.38 billion | Q3 2019: $2.34 billion | Q1 2020: $2.04 billion | Q2 2020: $2.03 billion | Q3 2020: $5.59 billion | Q1 2021: $5.56 billion | Q2 2021: $5.54 billion | Q3 2021: $6.27 billion | Q1 2022: $6.07 billion | Q2 2022: $6.01 billion | Q3 2022: $5.51 billion | Q1 2023: $5.64 billion | Q2 2023: $6.02 billion | Q3 2023: $5.87 billion | Q1 2024: $5.73 billion | Q2 2024: $5.46 billion | Q3 2024: $4.31 billion | Q4 2024: $4.28 billion | Q1 2025: $4.35 billion.
- Historical annual values: Fiscal year 2024: $4.28 billion | Fiscal year 2023: $5.74 billion | Fiscal year 2022: $5.45 billion | Fiscal year 2021: $6.03 billion | Fiscal year 2020: $5.57 billion | Fiscal year 2019: $2.33 billion | Fiscal year 2018: $2.44 billion | Fiscal year 2017: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: